Programmed death ligand-1 (PD-L1) clone 22C3 expression in resected colorectal cancer as companion diagnostics for immune checkpoint inhibitor therapy: A comparison study and inter-rater agreement evaluation across proposed cut-offs and predictive (TPS, CPS and IC) scores-Reference-Cited by-同舟云学术

Programmed death ligand-1 (PD-L1) clone 22C3 expression in resected colorectal cancer as companion diagnostics for immune checkpoint inhibitor therapy: A comparison study and inter-rater agreement evaluation across proposed cut-offs and predictive (TPS, CPS and IC) scores

Published:2024 Issue: Volume:38 Page:100788
ISSN:2468-2942
Container-title:Cancer Treatment and Research Communications
language:en
Short-container-title:Cancer Treatment and Research Communications

Author:

Lea Dordi,Zaharia Claudia,Søreide Kjetil^ORCID

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference62 articles.

1. PD-1/PD-L1 pathway: current researches in cancer;Han;Am. J. Cancer Res.,2020

2. Neoadjuvant immunotherapy in colorectal cancer beyond immune checkpoint inhibitors: emerging from bench to bedside;Kanani;Minerva Surg.,2023

3. Neoadjuvant immunotherapy in primary and metastatic colorectal cancer;Kanani;Br. J. Surg.,2021

4. PD-L1 as a biomarker of response to immune-checkpoint inhibitors;Doroshow;Nat. Rev. Clin. Oncol.,2021

5. Pembrolizumab in microsatellite-instability-high advanced colorectal cancer;André;N. Engl. J. Med.,2020

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PD-L1 Expression in Paired Samples of Rectal Cancer;Cancers;2024-07-21

2. PD-1/PD-L1 axis: implications in immune regulation, cancer progression, and translational applications;Journal of Molecular Medicine;2024-06-27

3. Evaluation of PD-L1 Expression in Colorectal Carcinomas by Comparing Scoring Methods and Their Significance in Relation to Clinicopathologic Parameters;Diagnostics;2024-05-13